Info

Endo Pharmaceuticals Holdings Inc., incorporated on November 18, 1997, is a specialty pharmaceutical company in pain management. The Company is engaged in the research, development, sales and marketing of branded and generic pharmaceutical products primarily to treat and manage pain. Its portfolio of branded products includes Lidoderm, Opana ER, Percocet, and Frova. The Company concentrates on generics that have one or more barriers to market entry, such as complex formulation, regulatory or legal challenges or difficulty in raw material sourcing. Its branded products pipeline includes three products in Phase III clinical trials, three products in Phase II clinical trials and one product in Phase I trials. During the year ended December 31, 2007, the branded products and non-branded generic portfolio comprised approximately 92% and 8%, respectively, of the Company's net sales.(Source: 10-K)